We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
27/7/2021 08:59 | Big pharma should be booming with the cash going into pharma over the next few years. FFS, the wind's behind us.We need a new leader who inspires confidence that we'll be in a position to benefit from those billions. | pierre oreilly | |
27/7/2021 08:57 | Nothing but good news for GSK, but the onslaught continues: GlaxoSmithKline Plc said the U.S. Food and Drug Administration has approved Shingrix for the prevention of shingles in adults aged 18 years and older who are or will be at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy. The company said Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine given intramuscularly in two doses, was initially approved by FDA in 2017 for the prevention of shingles in adults 50 years of age or older. | tradermichael | |
27/7/2021 08:33 | It will come back up later, normally drop gla | charlie9038 | |
27/7/2021 08:32 | Did you all think that I was joking yesterday? I was warning you about a serious profit warning similar to Benchkiser this morning now down a shocking 10% | abdullla | |
27/7/2021 08:05 | Open price not so good. I think we're getting dragged down a bit by AZN and possibly sector as a whole. But who knows, perhaps someone knows tomorrows figures? | netcurtains | |
26/7/2021 18:31 | It was close though. last trade: 1399.80 - Just missed 1400.00 by 20p | netcurtains | |
26/7/2021 18:21 | No,no,yes,no it's not sorted | mcflies | |
26/7/2021 16:47 | Did we manage to cling on to 1400 at close? Does that mean anything? What I do know nothing normally hinges on one day. Possibly Pharmas going down a bit because Covid19 looks like it might be sorted. | netcurtains | |
26/7/2021 16:26 | :-)) ((:- | abdullla | |
26/7/2021 16:05 | Arghhhhh. Man the pumps This is awful. I need to turn the computer off. | netcurtains | |
26/7/2021 15:59 | Elliots is Fake news further more GSK will deliver bad news on Wednesday on account of profit warnings,SP crashing today is to continue,imo | abdullla | |
26/7/2021 15:36 | AZN down hard today also. | alex1621 | |
26/7/2021 15:36 | Monty is always correct. If you say this is going to rocket one day, and this is going to crash the next, and this is going nowhere the next, you're going to be correct (and wrong too). | pierre oreilly | |
26/7/2021 15:31 | How the hell is EW is keeping her job. Surely if we want to see the S/P increase we need to get rid of her. AV is a prime example... | igoe104 | |
26/7/2021 15:27 | Pressure mounting on emma. Maybe elliott will increase their stake | spoole5 | |
26/7/2021 15:11 | Well Monty was correct (eventually)! spud | spud | |
26/7/2021 14:59 | BT and GSK both struggling awaiting news (I guess this week). No one wants to be holding the baby when the music stops. | netcurtains | |
26/7/2021 14:58 | GSK like a hot potato. | netcurtains | |
26/7/2021 14:34 | Rising Delta variant in the US possibly impacting their wider vaccine business may be one of the reasons for share price weakness, just imv obvs. | essentialinvestor | |
26/7/2021 13:12 | EW resignation RNS = Circa £1 on the share price. spud | spud | |
26/7/2021 12:02 | All - or then again, nothing much - will be revealed on Wed. The rest is speculation....... | keyno | |
26/7/2021 11:27 | There is no feasible way the status quo can remain whilst the share price keeps falling | spoole5 | |
26/7/2021 11:20 | The heat has gotta be rising. Another crucial week for Emma | spoole5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions